UBS Group’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $396K | Buy |
121,608
+121,503
| +115,717% | +$396K | ﹤0.01% | 5017 |
|
2025
Q1 | $215 | Sell |
105
-45
| -30% | -$92 | ﹤0.01% | 8562 |
|
2024
Q4 | $330 | Buy |
150
+112
| +295% | +$246 | ﹤0.01% | 8267 |
|
2024
Q3 | $64 | Sell |
38
-1,049
| -97% | -$1.77K | ﹤0.01% | 7996 |
|
2024
Q2 | $2.65K | Sell |
1,087
-570
| -34% | -$1.39K | ﹤0.01% | 7157 |
|
2024
Q1 | $7.82K | Sell |
1,657
-3,027
| -65% | -$14.3K | ﹤0.01% | 6189 |
|
2023
Q4 | $21.5K | Buy |
4,684
+4,563
| +3,771% | +$21K | ﹤0.01% | 5856 |
|
2023
Q3 | $315 | Sell |
121
-155
| -56% | -$404 | ﹤0.01% | 7443 |
|
2023
Q2 | $1.33K | Sell |
276
-1,585
| -85% | -$7.65K | ﹤0.01% | 6860 |
|
2023
Q1 | $12.3K | Buy |
1,861
+1,822
| +4,672% | +$12K | ﹤0.01% | 6361 |
|
2022
Q4 | $433 | Buy |
+39
| New | +$433 | ﹤0.01% | 8981 |
|
2022
Q3 | – | Sell |
-1,680
| Closed | -$10K | – | 9523 |
|
2022
Q2 | $10K | Buy |
1,680
+1,227
| +271% | +$7.3K | ﹤0.01% | 6940 |
|
2022
Q1 | $11K | Sell |
453
-721
| -61% | -$17.5K | ﹤0.01% | 7254 |
|
2021
Q4 | $56K | Buy |
+1,174
| New | +$56K | ﹤0.01% | 5705 |
|
2021
Q3 | – | Sell |
-839
| Closed | -$97K | – | 8637 |
|
2021
Q2 | $97K | Buy |
+839
| New | +$97K | ﹤0.01% | 4866 |
|
2021
Q1 | – | Sell |
-23
| Closed | -$6K | – | 8125 |
|
2020
Q4 | $6K | Sell |
23
-23
| -50% | -$6K | ﹤0.01% | 6736 |
|
2020
Q3 | $5K | Sell |
46
-37
| -45% | -$4.02K | ﹤0.01% | 6433 |
|
2020
Q2 | $9K | Sell |
83
-120
| -59% | -$13K | ﹤0.01% | 6230 |
|
2020
Q1 | $22K | Buy |
203
+30
| +17% | +$3.25K | ﹤0.01% | 5534 |
|
2019
Q4 | $18K | Buy |
173
+20
| +13% | +$2.08K | ﹤0.01% | 5879 |
|
2019
Q3 | $16K | Sell |
153
-174
| -53% | -$18.2K | ﹤0.01% | 5913 |
|
2019
Q2 | $34K | Sell |
327
-83
| -20% | -$8.63K | ﹤0.01% | 5369 |
|
2019
Q1 | $42K | Buy |
+410
| New | +$42K | ﹤0.01% | 4872 |
|
2018
Q3 | – | Sell |
-130
| Closed | -$13K | – | 7116 |
|
2018
Q2 | $13K | Hold |
130
| – | – | ﹤0.01% | 6069 |
|
2018
Q1 | $13K | Buy |
+130
| New | +$13K | ﹤0.01% | 5835 |
|